Huifen Chen

Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2

L. Pegram, Jake W. Anderson, David Vaisar, 2023, bioRxiv.

Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors.

John G. Moffat, L. Salphati, Huifen Chen, 2021, Journal of medicinal chemistry.

Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2

L. Pegram, Jake W. Anderson, David Vaisar, 2024, eLife.

Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2

L. Pegram, Jake W. Anderson, David Vaisar, 2023, bioRxiv.